Intelligence Platform
Patents
Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8728499
Dendritic macroporous hydrogels prepared by crystal templating
granted patentUS 8729248
Sperm-specific cation channel, CATSPER2, and uses therefor
granted patentUS 8729047
Compositions for inhibiting redox-sensitive GTPases
granted patentUS 8728806
Methods and compositions related to Th-1 dendritic cells
granted patentUS 8728724
Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneratio
granted patentUS 8728472
Antibodies that bind selectively to P25 and uses therefor
granted patentUS 8722716
Isoxazole treatments for diabetes
granted patentUS 8722871
VMP-like sequences of pathogenic borrelia species and strains
granted patentUS 8722628
Autophagy-inducing peptide
granted patentUS 8716258
Regulation of metabolism by miR-378
granted patentUS 8709391
Family of pain producing substances and methods to produce novel analgesic drugs
granted patentUS 8710017
Human and mouse targeting peptides identified by phage display
granted patentUS 8709430
Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospho
granted patentUS 8709342
Antimicrobial flush solutions
granted patentUS 8697034
Hyperpolarized 89-yttrium and methods relating thereto
granted patentUS 8686012
Stem cell differentiating agents and uses therefor
granted patentUS 8685406
Compositions of and method of using heat shock protein peptides
granted patentUS 8680094
1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment
granted patentUS 8669258
Treatment for gastroparesis using sepiapterin
granted patentUS 8668863
Dendritic macroporous hydrogels prepared by crystal templating
granted patentUS 8663649
Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease
granted patentUS 8658664
Cyclopamine tartrate salt and uses thereof
granted patentUS 8658778
hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer
granted patentUS 8658168
Compositions and methods for homoconjugates of antibodies which induce growth arrest of ap
granted